Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Helen Dakin

Helen Dakin

Helen Dakin

MSc DPhil

University Research Lecturer

Helen Dakin is a health economist specialising in assessing the cost-effectiveness of healthcare interventions. Her research interests include methods for trial and model-based economic evaluation, with particular focus on uncertainty, interacting healthcare decisions and factorial trials.

Helen has led and collaborated on the health economic analyses of numerous randomised controlled trials, models and observational studies. Current projects include: the KAT trial, which assesses the cost-effectiveness of different types of knee replacement component; the STAR trial, which evaluates radiotherapy alongside ranibizumab (Lucentis) in age-related macular degeneration; and the Supporting Women with adhErence to adjuvant Endocrine Therapy following breast cancer (SWEET) trial.

Helen co-leads the Patient Reported Outcomes and Health Economics module of the MSc in Clinical Trials and leads the HERC online short course Integrating Economic Evaluation into Clinical Trials.

Helen joined the Health Economics Research Centre in February 2008. In 2014, she completed a DPhil at the University of Oxford on the optimal methods for conducting economic evaluations of factorial clinical trials. She previously worked at Abacus International and completed her MSc in Economic Evaluation in Healthcare at City University. She graduated from Cambridge University with Masters and Bachelor's degrees in Biochemistry.

Research paper on factors influencing NICE decisions.